Riskpilot← Back to searchSign inGet full accessCUBIST PHARMACEUTICALS DANMARK ApS
APSDissolvedCVR 35528377Havneholmen 25Manufacture of pharmaceutical preparations · NACE 2120Est. 2013— employees
Revenue 2014
DKK -35K
EBITDA margin
100.0%
Equity ratio
72.0%
Financial strength
Net profit 2014
DKK -35K
| Revenue | DKK -35K | — |
| EBITDA | DKK -35K | — |
| Net profit | DKK -35K | — |
| Total assets | DKK 125K | — |
| Equity | DKK 90K | — |
| Employees | — | — |
Legal name
CUBIST PHARMACEUTICALS DANMARK ApS
CVR number
35528377
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
11. november 2013
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2014-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem alene eller af den samlede bestyrelse
Address
Havneholmen 25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 |
|---|---|
| Revenue | -35 |
| Staff expenses | -0 |
| EBITDA | -35 |
| Depreciation & amort. | -0 |
| EBIT | -35 |
| Net financials | 0 |
| Profit before tax | -35 |
| Tax | -0 |
| Net profit | -35 |
| Item | 2014 |
|---|---|
| Total assets | 125 |
| Equity | 90 |
| Long-term debt | 0 |
| Short-term debt | 35 |
| Total debt | 35 |
EBITDA margin
-3500000.0%
This company
15.8%
Market median
-22151999% vs market
20142014
Equity ratio
72.0%
This company
38.2%
Market median
+88% vs market
20142014
Return on equity
-38.9%
This company
18.4%
Market median
-311% vs market
20142014
Net profit margin
-3500000.0%
This company
8.1%
Market median
-43209977% vs market
20142014
Asset turnover
-0.28×
This company
1.12×
Market median
-125% vs market
20142014
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20142014
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AB Chief Executive Officer | Chief Executive Officer | 2015 – 2016 |
AO Chief Executive Officer | Chief Executive Officer | 2015 – 2016 |
| Name | Role | Member since |
|---|---|---|
| Former (8) | ||
| Board of Directors | 2015 – 2016 | |
| Board of Directors | 2013 – 2014 | |
| Chairman | 2014 – 2015 | |
| Board of Directors | 2014 – 2015 | |
| Board of Directors | 2014 – 2015 | |
| Board of Directors | 2014 – 2014 | |
| Chairman | 2013 – 2014 | |
| Board of Directors | 2015 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2013 | |
| Company | 100% | 100% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CUBIST PHARMACEUTICALS DANMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anita Bruhin | Chief Executive Officer | 0 companies |
| Anita Ouwerkerk | Chief Executive Officer | 0 companies |
| Christopher John Foreman | Board of Directors | 0 companies |
| Michael John Tomsicek | Board of Directors | 0 companies |
| Patrick Volkert Jozef Johannes Vink | Chairman | 0 companies |
| Timothy John Douros | Board of Directors | 0 companies |
| Boris Donatien Maxime Javelle | Board of Directors | 0 companies |
| Christian Dreger | Board of Directors | 0 companies |
| Thomas James DesRosier | Chairman | 0 companies |
| Torben Dahl | Board of Directors | 0 companies |